SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Zackova Daniela) "

Sökning: WFRF:(Zackova Daniela)

  • Resultat 1-4 av 4
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Lauseker, Michael, et al. (författare)
  • Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin
  • 2019
  • Ingår i: American Journal of Hematology. - : WILEY. - 0361-8609 .- 1096-8652. ; 94:11, s. 1236-1243
  • Tidskriftsartikel (refereegranskat)abstract
    • Chronic myeloid leukemia (CML) is usually diagnosed in chronic phase, yet there is a small percentage of patients that is diagnosed in accelerated phase or blast crisis. Due to this rarity, little is known about the prognosis of these patients. Our aim was to identify prognostic factors for this cohort. We identified 283 patients in the EUTOS population-based and out-study registries that were diagnosed in advanced phase. Nearly all patients were treated with tyrosine kinase inhibitors. Median survival in this heterogeneous cohort was 8.2 years. When comparing patients with more than 30% blasts to those with 20-29% blasts, the hazard ratio (HR) was 1.32 (95%-confidence interval (CI): [0.7-2.6]). Patients with 20-29% blasts had a significantly higher risk than patients with less than 20% blasts (HR: 2.24, 95%-CI: [1.2-4.0], P = .008). We found that the blast count was the most important prognostic factor; however, age, hemoglobin, basophils and other chromosomal aberrations should be considered as well. The ELTS score was able to define two groups (high risk vs non-high risk) with an HR of 3.01 (95%-CI: [1.81-5.00], P < .001). Regarding the contrasting definitions of blast crisis, our data clearly supported the 20% cut-off over the 30% cut-off in this cohort. Based on our results, we conclude that a one-phase rather than a two-phase categorization of de novo advanced phase CML patients is appropriate.
  •  
2.
  • Pfirrmann, Markus, et al. (författare)
  • The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
  • 2020
  • Ingår i: Leukemia. - : NATURE PUBLISHING GROUP. - 0887-6924 .- 1476-5551. ; 34:8, s. 2138-2149
  • Tidskriftsartikel (refereegranskat)abstract
    • Prognostic scores support clinicians in selecting risk-adjusted treatments and in comparatively assessing different results. For patients with chronic-phase chronic myeloid leukemia (CML), four baseline prognostic scores are commonly used. Our aim was to compare the prognostic performance of the scores and to arrive at an evidence-based score recommendation. In 2949 patients not involved in any score development, higher hazard ratios and concordance indices in any comparison demonstrated the best discrimination of long-term survival with the ELTS score. In a second step, of 5154 patients analyzed to investigate risk group classification differences, 23% (n = 1197) were allocated to high-risk by the Sokal score. Of the 1197 Sokal high-risk patients, 56% were non-high-risk according to the ELTS score and had a significantly more favorable long-term survival prognosis than the 526 high-risk patients according to both scores. The Sokal score identified too many patients as high-risk and relatively few (40%) as low-risk (versus 60% with the ELTS score). Inappropriate risk classification jeopardizes optimal treatment selection. The ELTS score outperformed the Sokal score, the Euro, and the EUTOS score regarding risk group discrimination. The recent recommendation of the European LeukemiaNet for preferred use of the ELTS score was supported with significant statistical evidence.
  •  
3.
  •  
4.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-4 av 4
Typ av publikation
tidskriftsartikel (4)
Typ av innehåll
övrigt vetenskapligt/konstnärligt (2)
refereegranskat (2)
Författare/redaktör
Baccarani, Michele (3)
Saussele, Susanne (3)
Guilhot, Joelle (3)
Prejzner, Witold (3)
Hasford, Joerg (3)
Koskenvesa, Perttu (3)
visa fler...
Pfirrmann, Markus (3)
Turkina, Anna (3)
Olsson-Strömberg, Ul ... (2)
Zaritskey, Andrey (2)
Clark, Richard E. (2)
Bogdanovic, Andrija (2)
Griskevicius, Laimon ... (2)
Sacha, Tomasz (2)
Colita, Adriana (2)
Cervantes, Francisco (2)
Hochhaus, Andreas (2)
Ossenkoppele, Gert (2)
Hoffmann, Verena S. (2)
Lauseker, Michael (2)
Ahlstrand, Erik, 197 ... (1)
Simonsson, Bengt (1)
Höglund, Martin (1)
Richter, Johan (1)
Castagnetti, Fausto (1)
Mayer, Jiri (1)
Indrak, Karel (1)
Labar, Boris (1)
Zupan, Irena (1)
Everaus, Hele (1)
Hehlmann, Rudiger (1)
Guilhot, François (1)
Hjorth-Hansen, Henri ... (1)
Mahon, Francois-Xavi ... (1)
Hehlmann, Ruediger (1)
Panayiotidis, Panayi ... (1)
Själander, Anders (1)
Söderlund, Stina (1)
Lotfi, Kourosh, 1966 ... (1)
Stenke, Leif (1)
Myhr-Eriksson, Krist ... (1)
Lübking, Anna (1)
Deneberg, Stefan (1)
Strömberg, Ulla Ohls ... (1)
Markevarn, Berit (1)
Gedde-Dahl, Tobias (1)
Janssen, Jeroen (1)
Lomaia, Elza (1)
Schubert-Fritschle, ... (1)
Bachl, Katharina (1)
visa färre...
Lärosäte
Uppsala universitet (4)
Umeå universitet (1)
Örebro universitet (1)
Linköpings universitet (1)
Karolinska Institutet (1)
Språk
Engelska (4)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (4)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy